AzTrials
AzTrials

TraumaNCT03219424

Predicting the Probability of Return To Work After Injury

An observational study of Trauma, run by Chinese University of Hong Kong at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To evaluate return to work (RTW) status after moderate and major trauma in Hong Kong at one year after injury. To derive reliable prediction models for return to work. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Trauma
How many people
1,115 participants
Where
1 siteHong Kong
Study dates
1 Sep 2017to 28 Feb 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All adult patients aged 18 years or above who enter into the trauma registry of the hospitals involved in the study between 1 September 2017 and 31 August 2018 inclusive will be included.

Who may be able to join

  • Aged 18 years or above
  • Eligible for the trauma registry
  • Working or seeking employment before injury

Who cannot join

  • Isolated hip or pathological fractures
  • Injury severity score (ISS) of 1
  • Patients who are unwilling to enter the study
  • Patients who have left Hong Kong

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Prince of Wales Hospital

    Shatin, NT

Other trials in Hong Kong

About this study

Official title: Predicting the Probability of Return to Work After Injury in Hong Kong: Prospective Multicentre Cohort Study

To evaluate return to work (RTW) status after moderate and major trauma in Hong Kong at one year after injury. To derive reliable prediction models for return to work.

Read the detailed description

Background:

Trauma is a leading cause not only of death worldwide but also of disability, and in Hong Kong it ranks sixth as a cause of death for all age groups. The implementation of trauma systems has improved the survival of injured patients in many settings including Hong Kong. However, the aim of trauma care for the injured person is not only to prolong life but also to restore patients to the best possible health status, and where applicable, to return to work. Survivors of trauma often experience late sequelae that have a major impact on almost all aspects of everyday life, and improvements in functional outcome and health status may continue for at least five years post-injury.

Objectives:

  1. to evaluate return to work (RTW) status after moderate and major trauma in Hong Kong at one year after injury;
  2. to derive reliable prediction models for RTW.

Study design:

This is a multi-centre, prospective long-term follow up cohort study of the 1163 trauma patients admitted to the Prince of Wales Hospital (PWH), Queen Elizabeth Hospital (QEH) and Tuen Mun Hospital (TMH) in Hong Kong in 2017-2018. Patients will be recruited within four weeks of ED attendance as soon as the patient is clinically stable and conscious. The follow-up period for return to work status of the 1163 trauma patients will extend from baseline to one year after trauma.

Conditions
Trauma
Keywords
Return to work status, Functional outcome, Quality of life
Medical subject headings
Wounds and Injuries

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Return to work status at 12 months after injury

    The proportion of trauma patients who return to work at 12 months after injury

    Measured: 12 months after injury

Secondary outcomes (1)
  1. Change of Glasgow Outcome Scale-Extended (GOSE) over time

    Change of GOSE over time

    Measured: On admission, 30 days after injury, 3 months after injury, 6 months after injury, 9 month after injury and 12 months after injury

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2017
  2. Study start1 Sep 2017
  3. Primary completion31 Dec 2019
  4. Study completion28 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,115 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03219424
Sponsor's protocol ID
CREC2016.667-T
Status last verified
Mar 2022
First submitted
7 Jul 2017
Last updated
5 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hung KKC, Leung LY, Yeung JHH, Wong TK, Yiu TY, Leung YK, Chan LPS, Wong JKS, Leung MPS, Goggins WB, Chan DYC, Lui CT, Ng WK, Ho HF, Cheng CH, Cheung NK, Graham CA. Return to work after injury in Hong Kong: prospective multi-center cohort study. Eur J Trauma Emerg Surg. 2022 Aug;48(4):3287-3298. doi: 10.1007/s00068-022-01899-x. Epub 2022 Feb 17.

    PubMed 35175362

Questions about this trial

What is this clinical trial studying?

An observational study of Trauma, run by Chinese University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Return to work status at 12 months after injury (time frame: 12 months after injury). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03219424, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in